Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₩1,447,425.72, with a 24-hour trading volume of ₩973.92B. The asset's market cap is ₩1.29P, after moving 0.19% in the last day.
Tokenized Eli Lilly And Co is trading at ₩1,449,163.8, with a tokenized market cap of ₩7.72B and a 24-hour trading volume of ₩4.43B. The tokenized asset has moved -1.76% in the past 24 hours.